ClinicalTrials.govpublic full text
NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy
progressive multifocal leukoencephalopathy, absolute lymphocyte count, safety and tolerability of nt-i7, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 846938
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.